130 related articles for article (PubMed ID: 25731298)
21. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers.
Elias D; Borget I; Farron M; Dromain C; Ducreux M; Goéré D; Honoré C; Boige V; Dumont F; Malka D; Pottier E; Caramella C
Eur J Surg Oncol; 2013 Nov; 39(11):1214-8. PubMed ID: 24044805
[TBL] [Abstract][Full Text] [Related]
22. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
23. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
24. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
[TBL] [Abstract][Full Text] [Related]
25. [A case of peritoneal dissemination that exhibited a complete response to systemic chemotherapy following the resection of primary colon cancer].
Okamura S; Murata K; Wada Y; Kato R; Makino S; Ohwada Y; Nishigaki T; Murakami M; Okada K; Yanagisawa T; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2270-2. PubMed ID: 23268046
[TBL] [Abstract][Full Text] [Related]
26. [Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma].
Mura G; Framarini M; Vagliasindi A; Cavaliere D; Tauceri F; Solfrini G; Milandria C; Verdecchia GM
Chir Ital; 2007; 59(2):217-23. PubMed ID: 17500178
[TBL] [Abstract][Full Text] [Related]
27. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study.
Bloemendaal AL; Verwaal VJ; van Ruth S; Boot H; Zoetmulder FA
Eur J Surg Oncol; 2005 Dec; 31(10):1145-51. PubMed ID: 16084051
[TBL] [Abstract][Full Text] [Related]
28. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
29. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
McConnell YJ; Mack LA; Francis WP; Ho T; Temple WJ
J Surg Oncol; 2013 May; 107(6):591-6. PubMed ID: 23129533
[TBL] [Abstract][Full Text] [Related]
30. Treatment results of peritonectomy combined with perioperative chemotherapy for colorectal cancer-patients with peritoneal carcinomatosis.
Yonemura Y; Ishibashi H; Sako S; Kitai T; Mizumoto A; Hirano M; Ichinose M; Takao N; Matsuda N; Togawa T; Ozamto Y; Chang-Yun L; Elnemr A; Li Y; Xiao-Jun Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1987-91. PubMed ID: 22202261
[TBL] [Abstract][Full Text] [Related]
31. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.
Hompes D; Aalbers A; Boot H; van Velthuysen ML; Vogel W; Prevoo W; van Tinteren H; Verwaal V
Colorectal Dis; 2014 Aug; 16(8):O264-72. PubMed ID: 24433532
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
[TBL] [Abstract][Full Text] [Related]
33. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery for synchronous and metachronous colorectal peritoneal dissemination: Japanese P classification and peritoneal cancer index.
Mizumoto A; Takao N; Imagami T; An B; Oe Y; Togawa T; Yonemura Y
Ann Gastroenterol Surg; 2024 Jan; 8(1):88-97. PubMed ID: 38250692
[TBL] [Abstract][Full Text] [Related]
35. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
[TBL] [Abstract][Full Text] [Related]
36. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.
Hall B; Padussis J; Foster JM
Surg Clin North Am; 2017 Jun; 97(3):671-682. PubMed ID: 28501254
[TBL] [Abstract][Full Text] [Related]
37. Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer.
Faron M; Macovei R; Goéré D; Honoré C; Benhaim L; Elias D
Ann Surg Oncol; 2016 Jan; 23(1):114-9. PubMed ID: 26014158
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.
Cashin PH; Dranichnikov F; Mahteme H
J Surg Oncol; 2014 Aug; 110(2):203-6. PubMed ID: 24846340
[TBL] [Abstract][Full Text] [Related]
39. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R
Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493
[TBL] [Abstract][Full Text] [Related]
40. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
